Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Braz. J. Pharm. Sci. (Online) ; 56: e18766, 2020. tab
Article in English | LILACS | ID: biblio-1249148

ABSTRACT

The therapeutic approaches for Type 2 Diabetes Mellitus rely most on the usage of oral hypoglycaemic drugs. These drugs have adverse side effects and hence alternative medicines are continuously explored. The present study intends to investigate the antidiabetic potential of the flavonoids present in Gracilaria corticata. The flavonoids were isolated (FEGC) and their inhibitory activity on the carbohydrate hydrolysing enzymes such as α-amylase and α-glucosidase was analysed. The flavonoids were found to inhibit α-amylase and α-glucosidase with an IC50 value of 302 µg and 75 µg respectively. The synergistic effect of FEGC and luteolin was also investigated and the results show that both FEGC and luteolin inhibited synergistically at half their IC50 values. The observations of this study reveal that the flavonoids of G. corticata have potential antidiabetic activity and can act independently or synergistically in the management of Type 2 Diabetes Mellitus


Subject(s)
Gracilaria/classification , Rhodophyta/adverse effects , Flavonoids/pharmacology , Pharmaceutical Preparations , Inhibitory Concentration 50 , Diabetes Mellitus, Type 2/pathology , Glucosidases/pharmacology , Amylases/adverse effects , Hypoglycemic Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL